Stephanie Roberts,Rachel Gainsbrugh
Stephanie Roberts
Utilization management opportunities for palivizumab for prophylaxis of respiratory syncytial virus complications in infants [0.03%]
婴幼儿预防呼吸道合胞病毒并发症使用帕利珠单抗的利用管理机会
Frederic R Curtiss,Kathleen A Fairman
Frederic R Curtiss
Economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Korea [0.03%]
韩国七价肺炎球菌结合疫苗用于儿童的经济学评价
Hyun Soon Sohn,Dong-Churl Suh,Eunjin Jang et al.
Hyun Soon Sohn et al.
Background: Streptococcus pneumoniae (sp) is a leading cause of invasive and noninvasive bacterial disease in children. 7-valent pneumococcal conjugate vaccine (PCV-7) has been shown to significantly reduce the incidence ...
Medical utilization associated with palivizumab compliance in a commercial and managed medicaid health plan [0.03%]
商业和管理 Medicaid 健康计划中与 Palivizumab 依从性相关的医疗服务利用情况
Jocelyn L Diehl,Jessica R Daw,Kim C Coley et al.
Jocelyn L Diehl et al.
Background: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections and hospitalization in infants. Palivizumab is currently the only available agent for prevention of RSV infection in...
Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization [0.03%]
某管理式医疗组织中帕利珠单抗预防呼吸道合胞病毒感染的预授权结果描述
Brieana C Buckley,Derek Roylance,Matthew P Mitchell et al.
Brieana C Buckley et al.
Background: Respiratory syncytial virus (RSV) is the leading cause of upper and lower respiratory tract infections in infants and young children. Most children are exposed to the virus before they are 2 years old and expe...
Kathleen A Fairman,Frederic R Curtiss
Kathleen A Fairman
No TREATment with darbepoetin dosed to hemoglobin 13 grams per deciliter in type 2 diabetes with pre-dialysis chronic kidney disease--safety warnings for erythropoiesis-stimulating agents [0.03%]
别嘌醇治疗2型糖尿病肾病患者至血红蛋白达13克/分升的安全性警告：促红细胞生成素刺激剂的风险与获益仍未知晓
Frederic R Curtiss,Kathleen A Fairman
Frederic R Curtiss
An exploratory comparison of medication lists at hospital admission with administrative database records [0.03%]
住院患者用药清单与行政数据库记录的探索性比较研究
Terri L Warholak,Matthew McCulloch,Alysson Baumgart et al.
Terri L Warholak et al.
Background: Medication reconciliation is recognized as important, but no one method has been recommended. Research has shown that the most common medication reconciliation errors are attributable to omitted medications an...
Empirical methods to calculate an erythropoiesis-stimulating agent dose conversion ratio in nondialyzed patients with chronic kidney disease [0.03%]
测算非透析慢性肾脏病患者促红细胞生成素剂量换算比的实证方法
Jeffrey Horowitz,Anil Agarwal,Fannie Huang et al.
Jeffrey Horowitz et al.
Background: Epoetin alfa and darbepoetin alfa are erythropoiesis-stimulating agents (ESAs) indicated for the treatment of anemia in chronic renal failure, including patients on dialysis and patients not on dialysis. Clini...
Jason Yeaw,Joshua S Benner,John G Walt et al.
Jason Yeaw et al.
Background: The National Quality Forum recently endorsed the proportion of days covered (PDC)-a measure of medication adherence-as an indicator of quality in drug therapy management. ...